Literature DB >> 2612540

Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.

L A Bauer1, K Murray, J R Horn, K Opheim, J Olsen.   

Abstract

Nine healthy adults were administered indocyanine green (ICG) 0.5 mg.kg-1 IV alone and after the administration of the following oral drugs: nifedipine 10 mg, propranolol 80 mg, propranolol 80 mg and nifedipine 10 mg, and propranolol 80 mg after nifedipine 10 mg every 8 h for 5 days. Heart rate and mean arterial blood pressure (MAP) were also determined. Nifedipine increased ICG clearance by 14% and decreased t1/2 by 26%. Propranolol decreased ICG clearance by 21% and increased t1/2 42%. Nifedipine and propranolol given together increased ICG clearance 63% and decreased t1/2 by 19%. All changes were statistically significant. Propranolol given after multiple doses of nifedipine did not change ICG kinetic parameters. Propranolol Cmax, tmax, oral clearance, and t1/2 did not change after nifedipine therapy. However, partial propranolol AUC values between 0-0.33, 0-0.5, 0-1.0 and 0-1.5 h were significantly larger after single and multiple doses of nifedipine indicating higher propranolol concentrations during the absorption phase. Heart rate and MAP did not change after nifedipine treatment. Similar declines in heart rate and MAP occurred after propranolol alone and propranolol after single and multiple doses of nifedipine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612540     DOI: 10.1007/bf00679780

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.

Authors:  M A Levine; R I Ogilvie; F H Leenen
Journal:  Clin Pharmacol Ther       Date:  1988-01       Impact factor: 6.875

3.  The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.

Authors:  J C McCourty; J H Silas; G T Tucker; M S Lennard
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

4.  Pharmacokinetics and pharmacodynamics of nifedipine in patients at steady state.

Authors:  L M Gutierrez; L J Lesko; R Whipps; N Carliner; M Fisher
Journal:  J Clin Pharmacol       Date:  1986 Nov-Dec       Impact factor: 3.126

5.  Measurement of nifedipine in plasma by gas--liquid chromatography and electron-capture detection.

Authors:  S R Hamann; R G McAllister
Journal:  Clin Chem       Date:  1983-01       Impact factor: 8.327

6.  Kinetics and dynamics of nifedipine after oral and sublingual doses.

Authors:  R G McAllister
Journal:  Am J Med       Date:  1986-12-15       Impact factor: 4.965

7.  (+)-Propranolol clearance, an estimation of hepatic blood flow in man.

Authors:  Y A Weiss; M E Safar; J P Lehner; J A Levenson; A Simon; J M Alexandre
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

8.  Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.

Authors:  J Feely
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

9.  Determination of propranolol in plasma by radial compression liquid chromatography with fluorometric detection.

Authors:  A el-Yazigi; C R Martin
Journal:  Clin Chem       Date:  1985-07       Impact factor: 8.327

10.  Inhibition of theophylline elimination by diltiazem therapy.

Authors:  A N Nafziger; J J May; J S Bertino
Journal:  J Clin Pharmacol       Date:  1987-11       Impact factor: 3.126

View more
  8 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs.

Authors:  Rachel H Rose; David B Turner; Sibylle Neuhoff; Masoud Jamei
Journal:  AAPS J       Date:  2017-05-19       Impact factor: 4.009

Review 3.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

4.  Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians.

Authors:  A Sowunmi; T J Rashid; O O Akinyinka; A G Renwick
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

Review 5.  Drug interactions with thrombolytic agents. Current perspectives.

Authors:  A de Boer; J M van Griensven
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

6.  Influences of the calcium antagonists nicardipine and nifedipine, and the calcium agonist BAY-K-8644, on the pharmacokinetics of propranolol in rats.

Authors:  I Vercruysse; D F Schoors; D L Massart; A G Dupont
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

7.  Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.

Authors:  P A Soons; A De Boer; A F Cohen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

8.  The influence of nifedipine and captopril on liver blood flow in healthy subjects.

Authors:  J Burggraaf; R C Schoemaker; J M Kroon; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.